TAU researchers use CRISPR to shrink cancer cells – study
Researchers at Tel Aviv University (TAU) successfully utilized CRISPR, a gene-editing technology, to remove a single gene from cancer cells in head and neck tumors. The study, conducted in animal models, resulted in the elimination of 50% of the tumors. The findings were published in the journal Advanced Science.
